Filing Flows

Filing Flows › Accendra Health (ACH) › Guidance & outlook

Accendra Health (ACH) guidance and outlook

Accendra Health's 10-Q filed Nov 6, 2026 makes 7 forward-looking statements.

Guidance and outlook

Accendra Health: what its forward-looking statements are about (10-Q filed 2026-11-06)Accendra Health: what its forward-looking statements are about (10-Q filed 2026-11-06)Other2Demand1Financing1Legal & regulation1Supply chain1Buybacks & dividends1
7 statements; tone +0.14 (−1 all cautious, +1 all confident); 3 hedged.
Accendra Health: outlook statements against the filing beforeAccendra Health: outlook statements against the filing beforeConfident1

Forward-looking statements, 10-Q filed Nov 6, 2026

Accendra Health's latest quarter

Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%, net loss $19.7M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.

Questions

What does Accendra Health expect?

On February 28, 2025, we announced that we were actively engaged in discussions regarding the anticipated sale of our Products & Healthcare Services (P&HS) business. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in general economic conditions may impact: (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us and (iii) our cost of borrowing. Our liquidity forecasts are based upon successful execution of our value creation

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.